Overview
Carcinomatosis of the peritoneal cavity involves the diffuse spread of malignant cells within the peritoneal lining, often complicating treatment and prognosis in oncology patients. 2Diagnosis
Imaging studies (CT, MRI) to assess extent and involvement 2
Peritoneal fluid analysis for cytology and tumor markers 2
Laparoscopy or exploratory surgery for definitive diagnosis and staging 2Management
First-line treatments: Cytoreductive surgery combined with heated intraperitoneal chemotherapy (HIPEC) 2
Adjunctive therapies: Epidural analgesia for postoperative pain management 2
Emerging therapies: CXCR4-targeted liposomes with antifibrotic agents (e.g., STS IIA and AMD3100) for managing complications like peritoneal fibrosis 1Special Populations
Postoperative pain management: Epidural analgesia is effective and well-tolerated in elderly patients undergoing complex surgeries like cytoreductive surgery with peritonectomy 2Key Recommendations
Utilize cytoreductive surgery followed by heated intraperitoneal chemotherapy (HIPEC) for optimal management of peritoneal carcinomatosis 2 (Evidence: Strong)
Implement epidural analgesia for postoperative pain control in patients undergoing cytoreductive surgery with peritonectomy to ensure adequate pain relief and minimal adverse events 2 (Evidence: Moderate)
Consider novel therapeutic approaches targeting CXCR4 pathways in combination with antifibrotic agents for managing complications associated with peritoneal fibrosis in long-term peritoneal dialysis patients, though further clinical validation is needed 1 (Evidence: Expert opinion)References
1 Asifullah K, Zhou Z, He W, Gao K, Khan MW, Faisal R et al.. CXCR4-Receptor-Targeted Liposomes for the Treatment of Peritoneal Fibrosis. Molecular pharmaceutics 2019. link
2 Piccioni F, Casiraghi C, Fumagalli L, Kusamura S, Baratti D, Deraco M et al.. Epidural analgesia for cytoreductive surgery with peritonectomy and heated intraperitoneal chemotherapy. International journal of surgery (London, England) 2015. link